TITLE

Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer

AUTHOR(S)
Singh, Pushpendra; Alex, Jimi; Bast, Felix
PUB. DATE
January 2014
SOURCE
Medical Oncology;Jan2014, Vol. 31 Issue 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
93504264

 

Related Articles

  • IGFR.  // Encyclopedic Reference of Cancer;2001, p443 

    An encyclopedia entry for "IGFR" is presented. The acronym stands for insulin-like growth factor receptors.

  • Combined inhibition of IGFR enhances the effects of gefitinib in H1650: a lung cancer cell line with EGFR mutation and primary resistance to EGFR-TK inhibitors. Yun Jung Choi; Jin Kyung Rho; Byung-suk Jeon; Su Jin Choi; Su Cheol Park; Seung Sook Lee; Hye-Ryoun Kim; Cheol Hyeon Kim; Jae Cheol Lee // Cancer Chemotherapy & Pharmacology;Jul2010, Vol. 66 Issue 2, p381 

    H1650 non-small cell lung cancer (NSCLC) cells display primary resistance to epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) although they have a deletion mutation on exon 19 of the EGFR gene. We investigated the effect of inhibition of both insulin-like growth factor...

  • Life without the IRS. Lienhard, Gustav E. // Nature;11/10/1994, Vol. 372 Issue 6502, p128 

    Reports on the role of insulin receptor substrate-1 (IRS-1) in growth and cellular signalling. Studies on the importance of IRS-1 on growth and glucose homeostasis; Independence of the signalling process by the insulin and insulin-like growth factors (IGF-1) from IRS-1; Description of the...

  • The novel functions of high-molecular-mass complexes containing insulin receptor substrates in mediation and modulation of insulin-like activities: emerging concept of diverse functions by IRS-associated proteins. Hakuno, Fumihiko; Fukushima, Toshiaki; Yoneyama, Yosuke; Kamei, Hiroyasu; Ozoe, Atsufumi; Yoshihara, Hidehito; Yamanaka, Daisuke; Shibano, Takashi; Sone-Yonezawa, Meri; Bu-Chin Yu; Chida, Kazuhiro; Takahashi, Shin-Ichiro // Frontiers in Endocrinology;May2015, Vol. 6, p1 

    Insulin-like peptides, such as insulin-like growth factors (IGFs) and insulin, induce a variety of bioactivities, such as growth, differentiation, survival, increased anabolism, and decreased catabolism in many cell types and in vivo. In general, IGFs or insulin bind to IGF-I receptor (IGF-IR)...

  • Insulin and insulin-like growth factor signalling in neoplasia. Pollak, Michael // Nature Reviews Cancer;Dec2008, Vol. 8 Issue 12, p915 

    Insulin and insulin-like growth factors (IGFs) are well known as key regulators of energy metabolism and growth. There is now considerable evidence that these hormones and the signal transduction networks they regulate have important roles in neoplasia. Epidermiological, clinical and laboratory...

  • Blocking IGF may be effective anti-cancer strategy. Bauman, Norman // Urology Times;Feb99, Vol. 27 Issue 2, p7 

    Reports on the potential of insulin-like growth factor (IGF) blockage as a treatment strategy for cancer. Results of an experiment on patients with malignant glioblastoma; Effects of the inhibition of the IGF receptor pathway to cell growth.

  • Possible Mechanism for Resistance to Herceptin.  // JNCI: Journal of the National Cancer Institute;12/19/2001, Vol. 93 Issue 24, p1829 

    Focuses on the mechanism for resistance to herceptin. Use of human breast cancer cell lines; Decrease in insulin-like growth factor-I receptor (IGF-IR) signaling; Association between IGF-IR signaling and the trastuzumab response.

  • Phosphorylated insulin-like growth factor 1 receptor is implicated in resistance to the cytostatic effect of gefitinib in colorectal cancer cells. Yang, Li; Li, Jianjun; Ran, Li; Pan, Feng; Zhao, Xiaoxin; Ding, Zhenyu; Chen, Yuying; Peng, Qiuping; Liang, Houjie // Journal of Gastrointestinal Surgery;Jun2011, Vol. 15 Issue 6, p942 

    Introduction: The ability of certain cancer cells to maintain signaling via the phosphoinositide-3-kinase/Akt and/or Ras/mitogen-activated protein kinase (MAPK) pathways has been repeatedly involved in resistance to epidermal growth factor receptor (EGFR)...

  • Ganoderic acid targeting multiple receptors in cancer: in silico and in vitro study. Gill, Balraj; Navgeet; Kumar, Sanjeev // Tumor Biology (Springer Science & Business Media B.V.);Oct2016, Vol. 37 Issue 10, p14271 

    Receptor tyrosine kinases (RTKs) are transmembrane high-affinity surface receptors responsible for cell migration, adhesion, apoptosis, metabolism, and cell proliferation activities in various cancers. Minute aberration in the RTK signaling modulates the downstream signaling pathways that...

  • BRET biosensor analysis of receptor tyrosine kinase functionality. Siddiqui, Sana; Wei-Na Cong; Daimon, Caitlin M.; Martin, Bronwen; Maudsley, Stuart // Frontiers in Endocrinology;Apr2013, Vol. 4, p1 

    Bioluminescence resonance energy transfer (BRET) is an improved version of earlier resonance energy transfer technologies used for the analysis of biomolecular protein interaction. BRET analysis can be applied to many transmembrane receptor classes, however the majority of the early published...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics